Skip to content

Comparison of Day 19 and Day 20 Artificial FET

Assessment of Artificial FET Reproductive Outcomes: Transfer of Blastocysts on Progesterone + 4 Versus Progesterone + 5

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02788097
Enrollment
130
Registered
2016-06-02
Start date
2016-05-31
Completion date
2016-10-31
Last updated
2017-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progesterone Induced Endometrial Receptivity

Keywords

blastocysts, progesterone, implantation, artificial frozen embryo transfer

Brief summary

In recent artificial frozen embryo transfers (FET) in which blastocysts vitrified on day 4 of culture and transferred on P+4, with blastocysts traditionally transferred on P+5, a high rate of implantation has been observed. In addition, a greater number of these implantations resulted in clinical pregnancies (i.e., a conceptus with normal fetal heart activity). In this prospective randomised control study, the investigators will investigate whether this increased viability, is due either to embryo quality, endometrial receptivity, or a combination of the two factors by randomizing the transfer of day 5 blastocysts to P+4 or P+5.

Detailed description

During the first 20 years of IVF embryo transfers were performed on days 1 to 3, even though evidence suggested that embryos dispelled into the uterus from fallopian tubes were at a post-compaction stage. This meant that initially all embryo transfers were asynchronous transfers. This strategy was imposed upon IVF by the vitro culture conditions of the time, which were sub-optimal for normal rates of blastocyst development. Transferred asynchronously cleavage stage embryos have to adapt to alien non- physio-metabolic conditions that may result in embryonic stress and compromised embryo development. In fresh embryo transfer this is further exacerbated by the supraphysiological hormone effects of controlled ovarian stimulation. In addition, there are mechanical factors (i.e. uterine contractility) and time factors, related to the endometrium (i.e., window of implantation) and embryo (i.e., time to hatching), that may reduce the chances of implantation. In contrast, to most other mammalian species the transfer of cleavage stage embryos to human uteruses led to acceptable levels of pregnancy and live birth. The regulation of synchrony between embryo and endometrium has not been fully addressed clinically in the human. This limitation affects IVF significantly in that up to 30% of embryo transfers may be affected by endometrial receptivity factors. The endometrium is a highly specialized, hormonally regulated tissue which is only receptive to embryo communication/interaction for a self-limiting period referred to as the window of implantation. Currently, there is no way to non-invasively determine the time of optimal receptivity, with IVF transfers performed on the assumption that the WOI was sufficiently wide enough to accommodate implantation in most patients and most treatments. During this period, the endometrial epithelium acquires optimal receptivity by progressing through specific structural, functional, and morphological changes induced by pre-ovulatory estrogen and progesterone and post-ovulatory progesterone, LH, and hCG. During the last three decades, there has been a major increase in the understanding of embryo physiology and correspondingly major improvements in the in vitro culture technologies used, in particular culture media and incubator technologies. These improvements have resulted in the culture of more good quality cleavage stage embryos and consequently blastocysts after extended culture, increasing embryo utility and the pregnancy capacity of an cycle. The increased implantation rates obtained with blastocyst transfers may be as much to do with embryo quality and stage, i.e., blastocysts have the required bi-directional communication competency needed for implantation, as with the WOI, i.e., the time of blastocyst formation and transfer coincides with the WOI of endometria. Moreover, the presently improved culture conditions may also be changing traditional embryo developmental milestones, in particular, the time to blastulation may be decreasing. An increasing number of blastocysts are being formed on day 4 of culture - ±100 hours post-insemination. Traditionally, day 4 embryos were only assessed for evidence of compaction, which is the developmental stage leading to blastulation and cell differentiation. Zygotes or embryos that reach developmental milestones first (i.e., syngamy, early cleavage, early compaction and early blastulation) are generally believed to have increased chances of normal developmental potential. In recent artificial frozen embryo transfers (FET) in which blastocysts vitrified on day 4 of culture and transferred on P+4, with blastocysts traditionally transferred on P+5, a high rate of implantation has been observed. In addition, a greater number of these implantations resulted in clinical pregnancies (i.e., a conceptus with normal fetal heart activity). In this prospective randomised control study, the investigators will investigate whether this increased viability, is due either to embryo quality, endometrial receptivity, or a combination of the two factors by randomizing the transfer of day 5 blastocysts to P+4 or P+5.

Interventions

artificial frozen embryo transfers

Sponsors

Antalya IVF
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

* a freeze-all cycle

Exclusion criteria

* patients who do not consent * patients who retract their consent * patients with day 4 blastocysts frozen * patients with no blastocysts frozen

Design outcomes

Primary

MeasureTime frameDescription
Biochemical Pregnancy1 year\>30IU/L of serum βhCG on day 14 of cycle

Countries

Turkey (Türkiye)

Participant flow

Participants by arm

ArmCount
Progesterone + 4
the transfer of day 5 blastocyst on the 5th day of progesterone supplementation Progesterone supplementation: artificial frozen embryo transfers
61
Progesterone + 5
the transfer of day 5 blastocysts on the 6th day of progesterone supplementation Progesterone supplementation: artificial frozen embryo transfers
69
Total130

Baseline characteristics

CharacteristicProgesterone + 5Progesterone + 4Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
69 Participants61 Participants130 Participants
Age, Continuous28.5 years
STANDARD_DEVIATION 3.2
28.2 years
STANDARD_DEVIATION 4.3
28.35 years
STANDARD_DEVIATION 3.75
Gender
Female
69 Participants61 Participants130 Participants
Gender
Male
0 Participants0 Participants0 Participants
Region of Enrollment
Turkey
69 participants61 participants130 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 610 / 69
serious
Total, serious adverse events
0 / 610 / 69

Outcome results

Primary

Biochemical Pregnancy

\>30IU/L of serum βhCG on day 14 of cycle

Time frame: 1 year

ArmMeasureValue (NUMBER)
Progesterone + 4Biochemical Pregnancy52.5 percentage of participants
Progesterone + 5Biochemical Pregnancy79.7 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026